Article
m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
BMC medical genomics - 18 Aug 2023
Fu Caizhu, Kou Ruirui, Meng Jie, Jiang Duanfeng, Zhong Ruilan, Dong Min
Abstract excerpt
BACKGROUND: N6-methyladenosine (m6A) has been confirmed to function critically in acute myeloid leukemia (AML) progression. Hitherto, the subtyping and prognostic predictive significance of m6A-correlated genes in AML is unclear. METHOD: From The Cancer Genome Atlas (TCGA-LAML), Therapeutically Applicable Research to Generate Effective Treatments (TARGET-AML) and Gene Expression Omnibus (GEO, GSE71014) databases,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
